Drawing for SHORTENING THE DISTANCE FROM LAB TO LIFE

USPTO serial 87394701

SHORTENING THE DISTANCE FROM LAB TO LIFE

Reviewed by CopyMark Law Group

Reg. 5394540Status 702Registered
Filing date
Status date
Registration date
Feb 6, 2018
Examiner
KELLY, JOHN M
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SHORTENING THE DISTANCE FROM LAB TO LIFE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael A. Geller

Michael A. Geller DLA Piper LLP (US)P.O. Box 64807Chicago, IL 60664-0807United States

Goods and services

ClassDescriptionStatusFirst use
035Marketing and advertising, information and data compiling and analyzing related to business management and clinical services; sales promotion services; consulting in sales techniques and sales programs; sales volume tracking for othersACTIVEOct 3, 2015
041Training services in the field of pharmaceutical salesACTIVEOct 3, 2015
042Clinical research services, namely, conducting clinical trials for others and related scientific clinical research services in the field of clinical trials to assist medical, biopharmaceutical and biotechnology companies with applications for drug approval; consulting services, namely, consulting in the field of contract clinical research and contract product development; Internet development, design and consulting services for others, namely, creating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and disease, creating an online community for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the communication and dissemination of medical and pharmaceutical informationACTIVEOct 3, 2015
044Promoting health information through direct-to-patient communications to promote patient adherenceACTIVEOct 3, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 6, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 6, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 4, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 6, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Oct 4, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 6, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 10, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 3, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 2, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 2, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 6, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 12, 2017ALIEASSIGNED TO LIE—
Sep 29, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 15, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 15, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2017DOCKASSIGNED TO EXAMINER—
Apr 6, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 4, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance